SciClone stops pancreatic cancer trial
October 2, 2009 on 11:08 pm | In Uncategorized | A Phase II trial evaluating a late-stage pancreatic cancer drug from SciClone Pharmaceuticals Inc. was stopped by an independent oversight committee. (SCLN)No Comments yet
Sorry, the comment form is closed at this time.
Powered by WordPress with Pool theme design by Borja Fernandez.